Article type
Abstract
Background: Midterm review of the national research uptake aims to provide timely information about the progress, research funding and other resources use for research under National research priority. This serves as a basis for decision-making to improve the performance of the research uptake and planning for medical research grant. The main purpose of the review of the research uptakes is to reduce inefficiency and poor performance on research outcome.
Objectives: The overall objective was to identify the uptake of health research priority and funding within Ministry of Health, Malaysia while improving patient outcomes during the years 2021-25.
Methods: A series of discussion with Cochrane trainers and Technical Working Groups (TWGs) were conducted to monitor and evaluate using national database from National Medical research register (NMRR) and documented all the priority research to evaluate the priority research uptake. The evaluation was guided by a framework with four categories (knowledge production, research targeting, informing policy development and impact on practice/services).
Results: A total of 6733 new research were proposed between 2021 to 2023 where 5446 (80.9%) of were primary research, 387 were systematic review using Cochrane Methods, of which 103 were systematic review coupled with Cochrane training and the remaining (900) research without National research grant (extramural). We found 27 reviews that have influenced primary research. Evidence from the National research uptake suggested that Cochrane Reviews play an important role in the uptake of more clinical research. Potential benefits of Cochrane Reviews included economic benefits through reduction of use of research fund, improve the research outcome, dissemination improvements in clinical quality, the reduction in the use of unproven or unnecessary procedures and improvements in patient and carer experiences.
Conclusions: This exercise identified several numbers of impacts on release of grant for priority research and improve the uptake of systematic review using the Cochrane method and save resources. We identified Cochrane Reviews which are more beneficial in targeting health-care policy and clinical practice.
Objectives: The overall objective was to identify the uptake of health research priority and funding within Ministry of Health, Malaysia while improving patient outcomes during the years 2021-25.
Methods: A series of discussion with Cochrane trainers and Technical Working Groups (TWGs) were conducted to monitor and evaluate using national database from National Medical research register (NMRR) and documented all the priority research to evaluate the priority research uptake. The evaluation was guided by a framework with four categories (knowledge production, research targeting, informing policy development and impact on practice/services).
Results: A total of 6733 new research were proposed between 2021 to 2023 where 5446 (80.9%) of were primary research, 387 were systematic review using Cochrane Methods, of which 103 were systematic review coupled with Cochrane training and the remaining (900) research without National research grant (extramural). We found 27 reviews that have influenced primary research. Evidence from the National research uptake suggested that Cochrane Reviews play an important role in the uptake of more clinical research. Potential benefits of Cochrane Reviews included economic benefits through reduction of use of research fund, improve the research outcome, dissemination improvements in clinical quality, the reduction in the use of unproven or unnecessary procedures and improvements in patient and carer experiences.
Conclusions: This exercise identified several numbers of impacts on release of grant for priority research and improve the uptake of systematic review using the Cochrane method and save resources. We identified Cochrane Reviews which are more beneficial in targeting health-care policy and clinical practice.